Drawing for 4ME

USPTO serial 87538308

4ME

Reviewed by CopyMark Law Group

Reg. 6639410Status 700Registered
Filing date
Status date
Registration date
Feb 8, 2022
Examiner
LOOK, JEFFREY J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with 4ME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joel E. Lehrer

Joel E. Lehrer GOODWIN PROCTER LLP100 NORTHERN AVENUEBOSTON, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of a mobile or desktop application that allows users to access personalized information about their medical condition and treatments and to navigate healthcare systems to understand and to seek as well as access treatment of said conditions; Downloadable software in the nature of a mobile or desktop application that allows users to learn about and connect with investigators conducting medical clinical trials which might offer experimental medication to treat specific diseases or conditions; Downloadable software that enables the collection of personalized data in the nature of medical records, claims history, test results, quality of life indicators, efficacy of particular medical treatments and/or safety/risks of medical treatments; Downloadable software in the nature of a mobile or desktop application that allows users access to an interactive medical diagnostic database; Downloadable software in the nature of a mobile or desktop application that allows users to compare costs and payment options information including available medical insurance plans and access programs; Downloadable software in the nature of a mobile or desktop application that allows users to access communities of other users with similar conditions and treatment journeys; Downloadable software for navigating the healthcare system; Downloadable software providing the user with the ability to access all of the information required to make an educated decision regarding a patient's healthcare options, including, but not limited to, personalized medical information, potential medical treatment options, information about current and upcoming clinical trials, quality of life indicators, comparative cost and payment options information including available medical insurance plans and access programs, personalized news, and personalized medical data collection; Downloadable software for accessing a database of ongoing or upcoming medical clinical trials; Downloadable software for accessing an interactive medical diagnostic database; Downloadable software for accessing a database of medical treatment pathways and options; Downloadable software for accessing patient communities that have similar conditions and treatment journeys; Downloadable software in the nature of a mobile or desktop application featuring information on health and wellness; Downloadable software in the nature of a mobile or desktop application that provides health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; Downloadable software in the nature of a mobile or desktop application that collects personalized, medical, quality of life and cost data for future assessments by a healthcare provider or other healthcare stakeholders; Downloadable electronic educational materials from the Internet, namely, newsletters, audiovisual, lectures, blogs, video logs, whitepapers, reports, photographs in the field of healthcareACTIVE—
038Providing multiple user access to data on the Internet in the field of medical patient records and educational materials all in the fields of healthcare, including pharmaceutical clinical trialsACTIVE—
041Providing non-downloadable educational materials via the Internet, namely, newsletters, audiovisual, lectures, blogs, video logs, whitepapers, reports, photographs in the field of healthcareACTIVE—
042Software as a service (SAAS) services featuring non-downloadable software for navigating the healthcare system; Software as a service (SAAS) services featuring non-downloadable software providing the user with the ability to access all of the information required to make an educated decision regarding a patient's healthcare options, including, but not limited to, personalized medical information, potential medical treatment options, information about current and upcoming clinical trials, quality of life indicators and personalized medical data collection; Software as a service (SAAS) services featuring non-downloadable software for accessing a database of ongoing or upcoming medical clinical trials;Software as a service (SAAS) services featuring non-downloadable software for accessing a database of treatment pathways and options; Software as a service (SAAS) services featuring non-downloadable software for accessing patient communities that have similar conditions and treatment journeys; Providing temporary use of non-downloadable software featuring a database of information on health and wellness; Providing temporary use of non-downloadable software that provides health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; Providing temporary use of non-downloadable software that collects personalized, medical and quality of life for future assessments by a healthcare provider or other healthcare stakeholders; Providing information and databases regarding pharmaceutical clinical trials accessed via the InternetACTIVEAug 25, 2021
044Healthcare services; Providing information on health conditions via an online website; Providing information, databases, medical patient records, and a website featuring educational information, all in the fields of healthcare accessed via the Internet; Providing information on health conditions via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Feb 8, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 6, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 5, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 20, 2021AMPBAMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED—
Oct 19, 2021ALIEASSIGNED TO LIE—
Oct 12, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 14, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 13, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 2, 2021IUAFUSE AMENDMENT FILED—
Sep 2, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2021EX4GSOU EXTENSION 4 GRANTED—
Mar 5, 2021EXT4SOU EXTENSION 4 FILED—
Mar 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 8, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 4, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 4, 2020EXT3SOU EXTENSION 3 FILED—
Sep 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 5, 2020EXT2SOU EXTENSION 2 FILED—
Mar 5, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 7, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 5, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 5, 2019EXT1SOU EXTENSION 1 FILED—
Sep 5, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 26, 2018ALIEASSIGNED TO LIE—
Dec 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 30, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 30, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 30, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 17, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2017DOCKASSIGNED TO EXAMINER—
Jul 29, 2017MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance